SPIA
ALT icon

Steward Partners Investment Advisory’s Altimmune ALT Stock Holding History

Steward Partners Investment Advisory’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$775K Buy
251,781
+6,388
+3% +$27.1K ﹤0.01% 1296
2025
Q4 		$886K Buy
245,393
+26,084
+12% +$114K ﹤0.01% 1126
2025
Q3 		$827K Buy
219,309
+5,925
+3% +$22.9K ﹤0.01% 1134
2025
Q2 		$826K Buy
213,384
+64,175
+43% +$347K 0.01% 1066
2025
Q1 		$746K Buy
149,209
+121,159
+432% +$767K 0.01% 1034
2024
Q4 		$202K Buy
28,050
+7,850
+39% +$60K ﹤0.01% 1607
2024
Q3 		$124K Buy
20,200
+6,750
+50% +$45.7K ﹤0.01% 1774
2024
Q2 		$89.4K Buy
13,450
+6,300
+88% +$46.5K ﹤0.01% 1833
2024
Q1 		$72.8K Buy
7,150
+6,150
+615% +$62.6K ﹤0.01% 1915
2023
Q4 		$11.3K Buy
+1,000
New +$4.17K ﹤0.01% 2656

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Steward Partners Investment Advisory's ALT Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its Altimmune (ALT) stake by 2.6% in Q1 2026, buying an estimated $27.1K and bringing the position to 251,781 shares worth $775K. The position accounts for ﹤0.01% of the portfolio, ranked #1296.

Steward Partners Investment Advisory first reported a position in ALT in Q4 2023 and has held it in 10 quarters since. The position peaked at $886K in Q4 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Steward Partners Investment Advisory held 251,781 shares of Altimmune worth $775K as of Q1 2026.
  • Steward Partners Investment Advisory bought 6,388 Altimmune shares in Q1 2026, an estimated $27.1K.
  • Altimmune made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #1296 holding.
  • Steward Partners Investment Advisory first reported a position in Altimmune in Q4 2023 and has held it in 10 quarters since.
  • Steward Partners Investment Advisory's Altimmune position peaked at $886K in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.